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Introduction
Protein aggregates are not normally observed in unstressed 
cells  because  of  the  cellular  quality  control  systems  that 
maintain cellular proteostasis by coordinating protein synthe­
sis and degradation (Balch et al., 2008; Powers et al., 2009). 
Prolonged cellular stress increases the burden on these quality 
control mechanisms, resulting in the accumulation and sub­
sequent  aggregation  of  proteins  linked  to  the  pathogenesis 
of numerous neurodegenerative disorders (e.g., Alzheimer’s 
disease,  Parkinson’s  disease,  Huntington’s  disease  [HD], 
and Lou Gehrig’s disease [amyotrophic lateral sclerosis] and 
prion encephalopathies; Ross and Poirier, 2004). Conditional 
G
enetic ablation of autophagy in mice leads to 
liver and brain degeneration accompanied by 
the appearance of ubiquitin (Ub) inclusions, 
which has been considered to support the hypothesis that 
ubiquitination serves as a cis-acting signal for selective 
autophagy. We show that tissue-specific disruption of the 
essential autophagy genes Atg5 and Atg7 leads to the 
accumulation of all detectable Ub–Ub topologies, arguing 
against  the  hypothesis  that  any  particular  Ub  linkage 
serves as a specific autophagy signal. The increase in   
Ub conjugates in Atg7
/ liver and brain is completely 
suppressed by simultaneous knockout of either p62 or 
Nrf2. We exploit a novel assay for selective autophagy in 
cell culture, which shows that inactivation of Atg5 leads to 
the selective accumulation of aggregation-prone proteins, 
and this does not correlate with an increase in substrate 
ubiquitination. We propose that protein oligomerization 
drives autophagic substrate selection and that the accu-
mulation of poly-Ub chains in autophagy-deficient cir-
cumstances is an indirect consequence of activation of 
Nrf2-dependent stress response pathways.
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selective autophagy in addition to its established role in protea­
some targeting (Kirkin et al., 2009c). How Ub might serve to 
specify such different fates for proteins sharing the same cyto­
plasm is not well understood but has been proposed to be en­
coded in Ub linkage topology (Pickart and Fushman, 2004). 
Ub has seven lysines, each of which can be linked to other 
Ubs to form a chain. All possible Ub–Ub linkages (including 
linear, mixed, and branched chains) have been identified in 
cells, but the physiological significance of most of these is 
unclear (Peng et al., 2003; Kim et al., 2007; Ikeda and Dikic, 
2008). Although K48­linked poly­Ub chains are considered to 
be  canonical  targeting  signals  for  proteasomal  degradation 
(Chau et al., 1989; Finley, 2009), proteasome inhibition leads 
to rapid accumulation of K48, K63, and K11 poly­Ub chains 
in mammalian cells (Bennett et al., 2007; Meierhofer et al., 
2008; Xu et al., 2009) and all non­K63 linkages in yeast (Xu 
et al., 2006), suggesting that K48 may not be unique in its 
ability to target proteins for degradation by the proteasome 
(Finley, 2009). K63­linked chains, in addition to established 
functions in endocytosis and DNA repair (Chen and Sun, 
2009), have been proposed to also serve as signals to direct 
misfolded or aggregated proteins to the autophagy pathway 
(Seibenhener et al., 2007; Olzmann and Chin, 2008; Tan et al., 
2008; Kirkin et al., 2009c).
Another established signal for autophagic substrate selec­
tivity is protein aggregation. For example, import of the vacuolar   
enzyme Ape1 (aminopeptidase 1) into the yeast vacuole is 
mediated by the cytoplasm to vacuole pathway, in which the 
substrate is recognized by a cytoplasmic receptor, Atg19, and 
encapsulated into autophagosomes that ultimately fuse with 
the vacuole (Scott et al., 2001). Formation of Ape1 oligomers, 
directed by an N­terminal presequence, is necessary and suffi­
cient for recognition by Atg19 (Kim et al., 1997). Thus, at least 
in yeast, aggregation is the best­understood mechanism for se­
lective cargo recognition by the autophagy pathway (Nair and 
Klionsky, 2005). Therefore, at least two modifications, ubiqui­
tination and oligomer formation, have been proposed to serve 
as cis­acting signals to promote selective autophagy. The extent 
to which either or both of these mechanisms function in the 
clearance of aggregated disease­associated proteins like htt and 
the mechanisms by which they are recognized by the autophagy 
system are unknown.
A leading candidate for this recognition process is p62, 
a ubiquitous component of inclusion bodies which contains an 
LC3 recognition sequence (Ichimura et al., 2008), which binds 
directly to LC3, an essential lipid­anchored protein on the sur­
face of preautophagosome and autophagosome membranes 
(Pankiv et al., 2007; Ichimura et al., 2008), and a Ub association 
(UBA) domain, which has been reported to bind selectively to 
K63­linked poly­Ub chains (Seibenhener et al., 2004; Tan et al., 
2008). Thus, the presence of both the LC3 recognition sequence 
and UBA domains in p62 has suggested a model in which p62 
serves as an adaptor that recruits ubiquitinated proteins to   
autophagosomes (Bjørkøy et al., 2005; Pankiv et al., 2007; Kirkin 
et al., 2009a; Lamark et al., 2009). Although the genetic dem­
onstration that p62 is required for the formation of Ub­positive 
inclusions in Atg7­null mice (Komatsu et al., 2007) and in a 
mouse models of neurodegeneration such as HD (Yamamoto 
et al., 2000), SCA1 (spinocerebellar ataxia type 1; Zu et al., 
2004), and tauopathy (Santacruz et al., 2005), in which ex­
pression of the mutant protein was turned off after the onset 
of pathogenesis, and inclusion body appearance established 
that there is a window of time during which neurons can re­
cover  from  the  proteotoxic  stress  induced  by  aggregation­
prone proteins and that neurons are capable of disaggregation 
and/or elimination of inclusion bodies. It is unlikely that the 
proteasome contributes directly to the destruction of these ag­
gregated proteins because substrates must be fully unfolded 
to be degraded by this protease (Finley, 2009). Indeed, the 
presence of intracellular protein aggregates in cell culture or 
in diseased brain tissue is associated with global disruption of 
ubiquitin (Ub) homeostasis and accumulation of undegraded 
proteasome substrates (Bence et al., 2001; Bennett et al., 2007). 
Macroautophagy (herein referred to as autophagy), the prin­
cipal means by which cells target cytoplasmic constituents to 
the lysosome or vacuole, has been proposed to serve as an alter­
nate pathway by which cells can eliminate protein aggregates 
(Kopito, 2000; Larsen and Sulzer, 2002). Because lysosomes 
are endowed with an acidic lumen and a battery of hydrolases, 
they are less dependent than proteasomes on unfolding of poly­
peptide substrates.
Morphological evidence of autophagosome proliferation 
in brains from patients and animal models of neurodegenera­
tive diseases, together with biochemical and morphological 
studies  in  tissue  culture  cells  overexpressing  aggregation­
prone proteins or exposed to proteasome inhibitors, suggests 
a tight linkage between pathogenic protein aggregation and 
induction of the autophagy pathway (for reviews see Nixon, 
2006; Williams et al., 2006). The significance of these obser­
vations was initially controversial because it was not clear 
from  those  studies  whether  the  induced  autophagosomes   
were part of a cytoprotective response or autophagy­associated   
cell death (for review see Nixon, 2006). However, knock­
down of the essential autophagy genes, Atg5 and LC3, leads 
to  the  accumulation  of  inclusion  bodies  and  detergent­ 
insoluble protein aggregates and retards the disappearance 
of aggregated huntingtin (htt) inclusions in cell culture mod­
els (Iwata et al., 2005; Yamamoto et al., 2006; Carra et al., 
2009). Together with the finding that brain­specific genetic 
ablation of Atg5 or Atg7 in mice induces a neurodegenera­
tive syndrome characterized by movement disorder, Ub pa­
thology and accumulation of insoluble protein aggregates, it 
is clear that autophagy plays an essential, constitutive cyto­
protective role in the brain, most likely by eliminating po­
tentially toxic protein aggregates (Hara et al., 2006; Komatsu 
et al., 2006, 2007). A key challenge is to determine whether 
and how protein aggregates are selectively recognized and 
targeted to the autophagy machinery.
The invariant presence of Ub in inclusion bodies in neuro­
degenerative diseases and models thereof (Alves­Rodrigues 
et al., 1998), together with the finding of Ub­positive inclu­
sions in the brains and livers of Atg5 or Atg7 knockout (KO) 
mice (Hara et al., 2006; Komatsu et al., 2006, 2007), has sug­
gested  the  hypothesis  that  Ub  might  serve  as  a  signal  for   539 Role of ubiquitin and aggregation in autophagy • Riley et al.
Pan et al., 2009) mass spectrometry to analyze the Ub species 
that accumulate in brains and livers of mice harboring tissue­ 
specific deletions of two genes that are essential for autoph­
agy, Atg5 and Atg7. We find that autophagy­deficient mice 
accumulate all detectable poly­Ub linkages in roughly equal 
proportion and that this accumulation is abrogated when the 
autophagy KO is genetically combined with KO of p62 or 
Nrf2, thus revealing a novel connection between integration 
of stress signaling pathways, autophagy, and Ub homeostasis. 
These  findings  lead  us  to  conclude  that  specific  poly­Ub 
chains are unlikely to be the key determinants of interaction 
with p62 or of autophagic fate. To assess the role of substrate ag­
gregation in autophagic targeting, we have exploited a novel 
flow cytometry–based assay, which shows that aggregation­ 
prone  proteins  accumulate  preferentially  over  diffuse  cytosolic 
proteins after inactivation of Atg5 and that this accumula­
tion  does  not  correlate  with  increased  poly­Ub–modified   
Drosophila melanogaster model of neurodegeneration (Nezis   
et al., 2008) confirms that p62 lies at the interface between pro­
tein aggregation, autophagy and Ub pathology, the inability to 
detect either significant binding affinity of p62’s UBA toward 
free Ub (Long et al., 2008) or unanchored tetra­Ub or selectiv­
ity toward K63 chains (Raasi et al., 2005; Kirkin et al., 2009b) 
challenges the Ub adaptor model. Moreover, recent studies have 
established a critical role for p62 in stabilizing Nrf2 (nuclear 
factor E2­related factor 2), a transcription factor which serves 
as the master regulator of one of the major cellular defense 
pathways that protects cells against oxidative and electrophilic 
stress (Liu et al., 2007; Komatsu et al., 2010). Therefore, it is 
possible that the involvement of p62 in inclusion body pathol­
ogy might reflect this role, as opposed to or perhaps in conjunc­
tion with its proposed function as an Ub adaptor.
In  this  study,  we  have  used  Ub  absolute  quantifica­
tion (AQUA; Gerber et al., 2003; Kirkpatrick et al., 2005;   
Figure 1.  Accumulation of Ub in autophagy-deficient brain. Ub profile from the 1% Triton X-100–soluble and –insoluble fraction of autophagy-deficient 
brain homogenates captured with P2UBA resin. (A) Age-matched control Atg7 littermates (Atg7
flox/+;nestin-Cre:p62
+/; denoted +) at 6 wk (open circles;   
n = 4) or Atg7 KO (Atg7
flox/flox;nestin-Cre:p62
+/; denoted ) at 6 wk (closed diamonds; n = 3) are shown. (B) Control Atg5 littermates (Atg5
flox/+;nestin-Cre;   
denoted +) at 16 (open circles; n = 4) and 26 wk (open diamonds; n = 3) or Atg5 KO (Atg5
flox/flox;nestin-Cre; denoted ) at 16 (closed circles; n = 4) and 
26 wk (closed diamonds; n = 3) are shown. Each symbol represents one animal. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005.JCB • VOLUME 191 • NUMBER 3 • 2010   540
depicted) from  autophagy­deficient mice. These data  do  not 
support a role for p62 in either the selective binding of proteins 
bearing poly­Ub chains or the recruitment of polyubiquitinated 
proteins to autophagic degradation.
An alternative explanation for the observation that p62 
ablation  suppresses  Ub  accumulation  and  inclusion  body 
formation in Atg7 KO mice (Komatsu et al., 2007) may be 
related to the recent demonstration that p62 plays a central 
role as an activator of the major cellular antioxidant stress 
response pathway mediated by the transcription factor Nrf2 
(Komatsu et al., 2010). In unstressed cells, binding of cyto­
plasmic Nrf2 to Keap1 (kelch­like ECH­associated protein 1), 
a BTB (broad complex, tramtrack, and bric a brac) domain 
substrate adaptor, results in its constitutive ubiquitination by 
a Cul3­Rbx Ub ligase and degradation by the proteasome (Li 
and Kong, 2009; Nguyen et al., 2009), thereby maintaining low 
substrate. These data lead us to propose that substrate oligo­
merization is a common mechanism for selective autopha­
gic cargo recognition and that in the absence of autophagy,   
aggregation­prone  substrates  accumulate,  resulting  in  the 
activation of stress response pathways that regulate global 
Ub homeostasis.
Results
Accumulation of all poly-Ub species in 
brain- and liver-specific autophagy KO 
mouse models
We reasoned that if specific poly­Ub linkages serve as selec­
tive signals for autophagy, those species should be enriched in 
tissues from mice in which the autophagy pathway has been 
disabled. To test this hypothesis, we used AQUA mass spec­
trometry to precisely quantify the abundance of tryptic pep­
tides derived from total Ub and the major (K48, K63, and K11) 
Ub–Ub chain linkages in digests of poly­Ub–enriched brain 
homogenates from mice harboring brain­specific disruption of 
Atg5 or Atg7 (Fig. 1). Although other poly­Ub linkages (K6, 
K27, K29, and K33) can be detected in these tissues, together 
they constitute <1% of the total Ub isopeptides (unpublished 
data) and, unless they were found to be significantly changed, 
were not included in this analysis. Significant elevation of   
total brain Ub was observed in Atg7­ and Atg5­null mice at as 
early as 6 wk of age (Fig. 1). Although the majority of brain 
Ub partitioned into a detergent­soluble fraction, the relative 
amount of Ub in the detergent­insoluble fraction increased 
with aging in all genotypes. By 26 wk, there was no further 
accumulation of soluble Ub species, suggesting that poly­Ub 
conjugates become less soluble with age. Importantly, Ub iso­
peptide species (K48, K63, and K11) increased in parallel in 
brain homogenates from both autophagy KO models. These 
findings, although consistent with a possible permissive role 
for poly­Ub chains in autophagy, fail to support the hypothesis 
that K63 (or any other particular poly­Ub linkage) serves as a 
signal to selectively target substrates to the autophagy path­
way. Instead, these data point to a possible role for autophagy 
in regulating global Ub levels.
We used mass spectrometry to assess the role of Ub in the 
formation of p62 inclusion bodies. KO of p62 suppressed the 
elevated levels of total Ub (Fig. 2 A) and poly­Ub chains in 
brains from 6­wk­old Atg7
/ mice (Fig. 2 B), indicating that 
Ub recruited into inclusion bodies in a p62­dependent fashion   
is not enriched in K63 or any other specific poly­Ub linkage. 
We were also unable to observe any measurable binding of   
either free Ub or poly­Ub chains to immobilized recombinant 
p62 UBA in vitro (Fig. S1), which is consistent with the very 
weak affinity of this domain previously reported for mono­Ub 
(Long et al., 2008) or unanchored Ub chains (Raasi et al., 2005; 
Kirkin et al., 2009b). AQUA mass spectrometry analysis showed 
that >97% of p62 in Atg7
/ mouse brain is not associated with 
Ub (Fig. S1 D), suggesting that the vast majority of cellular p62 
is  not  associated  with  polyubiquitinated  proteins.  Moreover, 
p62 levels did not increase in parallel with poly­Ub chains   
in detergent­insoluble extracts of livers (Fig. 3) or brains (not 
Figure 2.  Suppressed accumulation of Ub in Atg7-/p62-deficient brains. 
(A and B) Quantitative mass spectrometry analysis of P2UBA captured 
total (A) and isopeptide-linked (B) Ub from the soluble and insoluble frac-
tions of autophagy-deficient brains. Age-matched control Atg7 littermates 
(Atg7
flox/+:nestin-Cre:p62
+/; denoted +) at 6 wk (open circles; n = 4),   
p62 KO (Atg7
flox/flox:p62
/; denoted ) at 6 wk (closed circles; n = 3), 
Atg7 KO (Atg7
flox/flox:nestin-Cre:p62
+/; denoted ) at 6 wk (closed dia-
monds; n = 3), or Atg7-/p62-DKO (Atg7
flox/flox:nestin-Cre:p62
/) at 6 wk 
(closed triangles; n = 3) are shown. Each symbol represents one animal.   
*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005.541 Role of ubiquitin and aggregation in autophagy • Riley et al.
Nrf2 regulates the accumulation of all  
poly-Ub species in autophagy KO liver
To determine whether the accumulation of poly­Ub species in 
Atg7
/ liver is dependent on Nrf2, we assessed poly­Ub link­
ages in livers from Atg7
/, Nrf2
/, and Atg7­/Nrf2­DKO mice   
(Fig. 3). Similar to the results from autophagy­deficient brain,   
total Ub and K48, K63, K11, and K6 chains were all significantly 
elevated in livers from Atg7­null mice, indicating that we did not 
identify a difference in the response to autophagy ablation between 
brain and liver (Fig. 3). Although the increased Ub species in liver 
was primarily insoluble (Fig. 3), age determined in what fraction 
the Ub accumulated, as demonstrated by our results comparing 6­,   
16­, and 26­wk­old Atg5­null brain. At early times after Atg7 
ablation, such as 8 d after polyinosinic acid–polycytidylic acid 
(pIpC) injection in liver, the increase in Ub was in the soluble 
fraction, whereas by 28 d after pIpC injection, the increase in 
Ub was in the insoluble fraction (Komatsu et al., 2007), as was 
levels of Nrf2­activated gene expression. Oxidation of reac­
tive thiols within Keap1 under conditions of oxidative stress 
reduces its interaction with Nrf2, allowing Nrf2 to translocate 
into the nucleus, where it induces the transcription of cyto­
protective genes that contain antioxidant response elements 
(AREs; Rushmore et al., 1991; Venugopal and Jaiswal, 1996; 
Nioi et al., 2003; Hayes and McMahon, 2009). Recent data   
demonstrate that binding of p62 to Keap1 disrupts this inter­
action, leading to Nrf2 stabilization and increased translocation 
to the nucleus (Komatsu et al., 2010). Elevated levels of p62, 
resulting from autophagy deficiency in Atg7 KO mice, would 
thus be expected to promote Nrf2 stabilization and transcription 
of phase II antioxidant proteins. This hypothesis is supported 
by the finding that both the Nrf2 transcriptional response and 
hepatotoxicity, which are strongly activated in Atg7
/ liver, 
are attenuated in Atg7/Nrf2 double KO (DKO) liver (Komatsu 
et al., 2010).
Figure 3.  Suppressed accumulation of Ub in Atg7-/Nrf2-deficient livers. (A and B) Quantitative mass spectrometry analysis of P2UBA captured p62 (A), 
total (A), and isopeptide-linked (B) Ub from the soluble and insoluble fraction of autophagy-deficient livers (28 d after pIpC injection). Control littermates 
(F/F or F/F:Nrf2
+/; denoted +; open circles; n = 4), Nrf2 KO (F/F:Nrf2
/; denoted ; closed circles; n = 4), Atg7 KO (F/F:Mx1 or F/F:Mx1:Nrf2
+/; 
denoted ; closed diamonds; n = 6), or Atg7-/Nrf2-DKO (F/F:Mx1:Nrf2
/; closed triangles; n = 6) are shown. Each symbol represents one animal.   
**, P ≤ 0.01; ***, P ≤ 0.005.JCB • VOLUME 191 • NUMBER 3 • 2010   542
Figure 4.  Nrf2 transcription factor–binding sites are enriched among Ub-associated genes. (A) Enrichment of predicted transcription factor (TF)–binding 
sites in the promoter region (5,000 to 300) of Ub-associated genes versus its representation genome wide. The top 10 most enriched transcription   
factor–binding sites predicted among Ub-associated genes are labeled, with their enrichment scores (or Log10–transformed Benjamini–Hochberg-adjusted 
p-values) plotted against its occurrence. (B) Elevated Ub mRNA levels from Atg5-deficient brains. Total RNA was extracted from control Atg5 littermates 
(Atg5
flox/+;nestin-Cre) at 16 wk or Atg5 KO (Atg5
flox/flox;nestin-Cre) at 16 wk (n = 4 for each genotype; **, P ≤ 0.01) and the amount of transcript 
from Ubc, Ubb, Uba52, and Uba80 genes was quantified using real-time RT-PCR and normalized to actin. Error bars indicate SEM. au, arbitrary unit.   543 Role of ubiquitin and aggregation in autophagy • Riley et al.
(C) Gene expression analysis of Ub-associated Nrf2 targets mapped to mouse orthologues. Probes detecting transcripts exhibiting differential expression 
(Benjamini–Hochberg-adjusted P < 0.05) in at least one of the four comparisons are shown. Heat map represents Log2 (fold changes) with respect to either 
wild type (WT) or Atg7 KO (as indicated). Labels show the symbol, RefSeq (accession numbers from the NCBI Nucleotide database), gene probe name, 
and the gene row and gene column (i.e., array coordinates).
 
also reflected by our mass spectrometry results of 28 d after pIpC­
injected liver (Fig. 3). Although Nrf2 ablation alone did not influ­
ence total Ub or poly­Ub levels, the increase in these Ub species 
in  Atg7
/  livers  was  abrogated  in  Atg7­/Nrf2­DKO  (Fig.  3), 
indicating that accumulation of poly­Ub species in autophagy­ 
deficient liver requires the transcription factor Nrf2. Together, 
these data fail to support the conclusion that specific poly­Ub chain 
topologies serve as signals to selectively target Ub­conjugated 
proteins to p62 or to the autophagy pathway. Instead, our data 
together with recent findings from Komatsu et al. (2010) support   
the conclusion that p62 may play an important and hitherto un­
appreciated regulatory role at the interface between oxidative 
stress sensing and control of protein degradation pathways.
We used bioinformatics and functional genomics to as­
sess whether Nrf2 might activate the Ub pathway or Ub­ 
associated genes as part of a general stress response detoxifica­
tion mechanism. To this end, we determined whether AREs were 
enriched in Ub or Ub­associated genes, defined by annotation 
information from the UniProt database (UniProt Consortium, 
2008), Gene Ontology (Ashburner et al., 2000), and Panther 
classification (Thomas et al., 2003) systems. We found that Nrf2 
(and  its  heterodimeric  binding  partner  Maf,  musculoaponeu­
rotic fibrosarcoma oncogene) sites are enriched in Ub­associated 
genes compared with other transcription factor sites (P = 0.0087;   
Fig. 4 A) and that Ub­associated genes are significantly en­
riched among Nrf2 targets (not depicted). Previously, one Ub 
gene, UbC, was reported to contain an ARE consensus sequence 
(Rangasamy et al., 2004); however, our analysis, which incorpo­
rated stringent conservation information across four organisms, 
did not identify AREs within any of the Ub genes, although by   
RT­PCR we did detect a small increase in one Ub gene (Fig. 4 B).   
In support of the hypothesis that Nrf2 regulates expression of 
Ub­associated genes during autophagy deficiency, microarray analy­
sis showed significant changes in numerous Ub­associated Nrf2 
targets in Atg7
/ livers that returned to wild­type levels in the 
Atg7­/Nrf2­DKO livers (Fig. 4 C), of which we validated a few by 
quantitative real­time PCR (Fig. S2). Moreover, computational 
mapping of the second order network of core autophagy compo­
nents revealed an enrichment of Ub­associated Nrf2 targets within 
the autophagy network compared with the genome (Fig. 5 A);   
several of these targets were changed in the Atg7
/ livers and re­
turned to wild­type levels in the Atg7­/Nrf2­DKO livers (Fig. 5 B). 
 These data suggest an unexpected degree of interconnectivity be­
tween Nrf2/p62 stress signaling, autophagy, and Ub homeostasis 
and provide a plausible alternative explanation for the observed 
p62 dependence of Ub accumulation in Atg7 KO mice.
Selective accumulation of mutant htt after 
loss of autophagy
The accumulation of all Ub species in neural and liver­specific 
Atg5­ and Atg7­deficient models and the dependence on Nrf2 
led us to speculate that there must be additional features of a 
protein besides the presence of a poly­Ub chain that specify 
substrate targeting to autophagy. By analogy to the cytoplasm 
to vacuole pathway in yeast, in which oligomerization of AP­1   
drives selective autophagy, we hypothesized that substrate 
oligomerization may constitute a signal for selective autophagy 
in mammals. To test this hypothesis, we developed a flow   
cytometry–based strategy to assess selective autophagy in mam­
malian cells. We constructed bicistronic reporters that express a 
5 green fluorescent test protein, translated in a cap­dependent 
manner, together with a 3 reference protein, translated from 
an internal ribosome entry site (IRES; Fig. 6 A; Pestova et al., 
2001; Ngoi et al., 2004; Santacruz et al., 2005). We used cherry 
fluorescent protein (chFP), which is very stable when expressed 
in mammalian cells (Shaner et al., 2005), as the reference pro­
tein. Because both fluorescent fusion proteins are simultane­
ously expressed under the control of the same cytomegalovirus 
promoter, their relative rates of synthesis should be equal, and 
thus changes in their relative steady­state abundance reflect dif­
ferent rates of degradation (Yen et al., 2008). To assess the role 
of autophagy in degrading the two fusion proteins, we stably 
expressed these constructs in m5­7 cells, an Atg5
/ mouse   
embryo fibroblast line harboring the Atg5 gene under the con­
trol  of  a  doxycycline  (dox)­repressible  promoter  (Hosokawa 
et al., 2006). The addition of dox to parental m5­7 cells or to 
lines expressing constructs composed of htt exon 1–GFP in the 
test position resulted in substantial depletion of phosphatidyl­
ethanolamine­modified LC3 (LC3­II; a marker of autophago­
some formation; Fig. 6 B), as previously reported for m5­7 cells   
(Hosokawa et al., 2006), indicating that expression of these 
constructs does not affect the ability of Atg5 to be controlled by 
dox. After the addition of dox, there was no detectable change 
in the starvation­induced autophagy substrate, lactate dehydrog­
enase (LDH), or a substrate of chaperone­mediated autophagy, 
glyceraldehyde­3­phosphate dehydrogenase (GAPDH; Fig. 6 C;   
Cuervo et al., 1994, 1997).
To  test  the  hypothesis  that  aggregation­prone  proteins 
are selective autophagy substrates compared with stable, mono­
meric cytosolic proteins, we used htt exon 1, htt(Q47)­GFP, 
with an expanded poly­Gln tract that promotes aggregation as 
the test protein and chFP as the reference. As a control, we used 
the nonpathogenic htt(Q25)­GFP, which differs from htt(Q47)­
GFP only in lacking the poly­Gln expansion and the propensity 
to aggregate (Busch et al., 2003). In the absence of dox, neither 
htt fusion protein was detectable by immunoblot (Fig. 6 C), and 
green fluorescence levels were similar to those of parental m5­7   
cells (not depicted). The addition of dox led to a robust increase 
in htt(Q47)­GFP immunoreactivity (Fig. 6 C) and green fluores­
cence (Fig. 6 D), which was detectable after an initial lag of 
48–72 h, correlating well with the time course of LC3­II dis­
appearance. To confirm that dox addition does not affect the JCB • VOLUME 191 • NUMBER 3 • 2010   544
the autophagic substrate selectivity of htt(Q47)­GFP compared   
with chFP or htt(Q25)­GFP, we used two­color flow cytometry 
(Fig. 6 D). We used the ratio of relative increase in green and red 
fluorescence, assessed by two­color flow cytometry, in response 
to dox to generate the autophagic selectivity index (ASI). With 
htt(Q25)­GFP in the test position, the ASI at t = 100 h was close 
to 1, indicating the same amount of basal autophagy of the 
test and reference reporters (Fig. 6 D), and loss of autophagy 
did not result in increased cell death (Fig. 6 E). In contrast,   
with htt(Q47)­GFP as the test protein, the ASI at t = 100 h was 2   
(Fig. 6 D) and corresponded with a substantial increase in 
cell death (Fig. 6 E). Overall, these data demonstrate that the   
aggregation­prone fragment containing an expanded polyQ tract 
selectively accumulates over monomeric, cytoplasmic proteins 
after autophagy inhibition and that autophagy is pivotal in re­
ducing the toxicity of aggregation­prone proteins.
To determine whether accumulation of a selective autoph­
agy substrate correlates with an increase in a specific poly­Ub 
species, which would be expected if a specific Ub conjugate 
served as a targeting signal, we used Ub AQUA analysis to   
relative rates of cap­dependent and ­independent translation, 
we monitored incorporation of [
35S]Met into htt(Q47)­GFP and 
chFP (Fig. S3 A). Although cap­independent translation from an 
IRES can increase during cellular stress (Fernandez et al., 2002; 
Kozak, 2005), we did not measure a significant difference in the 
relative rates of incorporation of [
35S]Met into htt(Q47)­GFP 
and chFP in cells treated with dox for 72 or 96 h (Fig. S3 A).   
Additionally, Northern blot analysis confirmed that the transcript 
was the expected size and failed to reveal increased levels of 
htt(Q47)­GFP­IRES­chFP mRNA in response to dox (Fig. S3 B).   
Together, these data indicate that m5­7 cells efficiently degrade 
htt(Q47)­GFP in a manner that depends on continued expres­
sion of Atg5. Addition of the proteasome inhibitor MG132, in 
the absence of dox, resulted in increased htt(Q47)­GFP and 
chFP levels, indicating that the proteasome contributes to the 
degradation of both proteins. However, addition of MG132 
and dox resulted in an additive increase in htt(Q47)­GFP yet 
minimal increase in chFP (Fig. S3 C). Thus, chFP is primar­
ily a proteasome substrate, whereas htt(Q47)­GFP can partition 
between the proteasome and autophagy pathways. To determine 
Figure 5.  Ub-associated Nrf2 targets are enriched in the autophagy network. (A) A second-order network centered on the core autophagy components 
(orange nodes) identified via PPIs showed an enrichment (hypergeometric P = 0.01) of Ub-associated Nrf2 targets (red nodes) in the network. (B) Venn 
diagram showing the various counts and overlaps between the microarray and network analysis. Also shown are the Ub-associated Nrf2 targets featured 
in the autophagy network mapped to mouse orthologues. Probes detecting transcripts exhibiting differential expression (Benjamini–Hochberg [BH]-adjusted 
P < 0.05) in at least one of the four comparisons are shown. Heat map represents Log2 (fold changes) with respect to either wild type (WT) or Atg7 KO 
(as indicated). Labels show the symbol, RefSeq (accession numbers from the NCBI Nucleotide database), gene probe name, and the gene row and gene 
column (i.e., array coordinates).545 Role of ubiquitin and aggregation in autophagy • Riley et al.
Nagaoka et al., 2004) led to the proposal that it serves as   
an adaptor that targets proteins for degradation by autophagy 
(Bjørkøy et al., 2005). This model is not consistent with our 
data showing that p62 levels do not increase in parallel with Ub 
chains in detergent­insoluble extracts from autophagy­deficient 
mice and that Ub­associated p62 does not constitute a signifi­
cant fraction of total p62. Consistent with our work showing 
that p62 regulates global Ub metabolism through Nrf2 rather 
than through direct binding, previous studies have failed to de­
tect significant affinity between p62’s isolated UBA domain and 
unanchored Ub chains (Raasi et al., 2005; Kirkin et al., 2009b) 
and demonstrated that the p62 UBA domain interacts with Ub   
with 0.5 mM or weaker affinity (Long et al., 2008). However,   
Ub binding by p62 likely requires p62 oligomerization (Kirkin 
et al., 2009b). Data from Kirkin et al. (2009b) showed that   
in vitro translated p62 binds to GST­Ub (or GST­4xUb) and is in 
part dependent on an intact p62 PB1 (Phox and Bem1p) domain 
that mediates p62 oligomerization. We attempted to mimic the 
avidity­based binding made possible by oligomerization by cova­
lently conjugating p62’s UBA domain to beads and still failed to 
observe Ub binding, perhaps suggesting that PB1­mediated p62 
oligomerization may array UBA domains in a geometry condu­
cive to binding Ub that is not recapitulated on beads. We can­
not completely rule out the direct involvement of p62’s UBA 
domain  in  Ub­dependent  autophagic  substrate  degradation; 
however, our Ub measurements in the context of Atg7 and p62 
or Nrf2 DKO tissues are in agreement with recent data impli­
cating p62 as an activator of the Nrf2­mediated stress response 
pathway (Liu et al., 2007; Komatsu et al., 2010) together with 
data demonstrating Nrf2 (Ishii et al., 2000) and Maf (Jain et al., 
2010) regulation of p62. Although, we were unable to identify 
with confidence any Nrf2 ARE sites for p62, even if we ex­
tended the search to 10 kb upstream, Jain et al. (2010) reported 
the existence of a Maf motif in p62’s promoter and showed that 
Nrf2 itself does not bind to this Maf element but that the Nrf2–
MafG  complex  does.  Together,  these  data  suggest  the  exis­
tence of an Nrf2:p62 feedback loop. We propose that increased 
soluble p62, resulting from Atg7 depletion, leads to inhibition 
of Keap1 binding, stabilization of Nrf2, and, consequently, in­
creased transcription of Nrf2­dependent genes, including those 
directly affecting Ub metabolism.
Our observation that aggregation rather than ubiquitination 
status strongly correlates with selective accumulation of mutant 
htt after Atg5 inactivation supports the hypothesis that aggrega­
tion or oligomerization is a key signal for substrate capture by   
the autophagosome. Substrate oligomerization as a cis­acting se­
lective autophagy feature is not unique to misfolded aggregation­
prone proteins because the autophagy substrates P granules   
(Zhang et al., 2009) and midbody rings (Pohl and Jentsch, 
2009) all oligomerize and form inclusions after inactivation of 
autophagy in the absence of evidence of their modification with 
poly­Ub. Moreover, although p62 accumulates in Atg7
/ mice, 
it was not highly enriched on Ub­associated affinity beads, sug­
gesting that degradation of this selective autophagy substrate 
also correlates poorly with ubiquitination status. Although our 
data do not support the hypothesis that covalent poly­Ub conju­
gation to substrates is the targeting signal for selective autophagy, 
assess total Ub and K48, K63, K11, and K6 isopeptides. The 
addition of dox to cells expressing htt(Q25)­GFP did not result 
in increased Ub species in either soluble or insoluble fractions, 
which is consistent with previous studies showing the absence of 
Ub­positive inclusions in unstressed Atg5 KO cells (Szeto et al., 
2006; Kuma et al., 2007). Although expression of htt(Q47)­
GFP alone did not lead to changes in the levels of Ub species, 
the addition of dox to cells expressing htt(Q47)­GFP led to ac­
cumulation of total Ub and all major Ub species in the insoluble 
fraction (Fig. 6 F). Moreover, the amount of Ub­associated 
htt(Q47)­GFP was <0.05 pmol/mg, representing <0.1% of the 
total Ub species that accumulated in htt(Q47)­GFP cells after 
autophagy shutoff (Fig. 6 F). These data suggest that a specific 
Ub  conjugate  does  not  target  the  aggregation­prone  protein, 
htt(Q47)­GFP, for selective autophagy and that the increased 
Ub levels observed in autophagy­deficient cells are not caused 
by increased substrate ubiquitination.
Discussion
Accumulation of poly­Ub conjugates within intracellular inclu­
sion bodies in response to loss or inactivation of the autophagy 
system is consistent with the hypothesis that polyubiquitination 
of proteins serves as a cis­acting signal for their selective rec­
ognition by and targeting to the autophagy machinery (Kirkin   
et al., 2009c). Alternatively, it is possible that loss of function or 
capacity in the autophagy pathway leads to activation of cellular 
stress response systems that increase the net balance between 
Ub conjugation and deconjugation. In this study, we observed 
that all detectable poly­Ub linkage topologies increase in par­
allel after loss of autophagy in three different mouse models 
of autophagy deficiency and in tissue culture cells after se­
lective  inactivation  of  the  autophagy  pathway. These  results 
do not support the hypothesis that a unique Ub–Ub linkage 
topology is a cis­acting signal for selective substrate recogni­
tion by autophagy. Our inability to detect increased levels of 
Ub conjugation to autophagy substrates after inactivation of the 
core autophagy machinery, together with our observation of a 
tight correlation between aggregate formation and autophagic 
substrate selection, led us to propose that protein oligomeriza­
tion drives autophagic substrate specificity. We propose that 
accumulation of poly­Ub chains in autophagy deficiency is an 
indirect consequence of p62­mediated activation of the Nrf2­
dependent stress response pathway. Stabilization of Nrf2 and 
up­regulation of ARE­containing genes have been observed in 
several neurodegenerative disorders, although it remains to be 
determined whether sustained Nrf2 signaling plays a protective 
or causative role in these neurodegenerative disorders (de Vries 
et al., 2008; Johnson et al., 2008; van Roon­Mom et al., 2008). 
Interestingly, the accumulation of all Ub species in Atg7
/ and 
Atg5
/ mice is similar to the effect of expression of mutant 
htt in HD transgenic models and human HD patients (Bennett   
et al., 2007), suggesting that accumulation of Ub conjugates in 
all of these conditions may be the consequence of activation of 
related stress response pathways.
The presence of a UBA domain in p62 and its consistent   
enrichment in Ub­positive inclusion bodies (Zatloukal et al., 2002; JCB • VOLUME 191 • NUMBER 3 • 2010   546
Figure 6.  Flow cytometry assay to quantify selective autophagy. (A) Diagram of the bicistronic reporter construct. Ribosomes are recruited to both the 
5 end of the bicistronic construct to translate the test fusion protein fused to GFP and at the IRES to translate the stable, nonaggregating reference protein 
chFP. The test protein is either htt exon 1 with a nonpathogenic poly-Gln repeat htt(Q25) fused to GFP or htt with an expanded poly-Gln tract, htt(Q47)-GFP, 
which promotes aggregation. (B) The addition of dox for 96 h decreased autophagy in the bicistronic stably expressing cell lines similar to the parental 
line, m5-7, as measured by the decreased levels of phosphatidylethanolamine-modified LC3 (LC3-II). (C) Western blot (WB) analysis of the accumulation of 
htt(Q)-GFP after autophagy shutoff. At steady-state (t = 0 h), the levels of both htt(Q25)-GFP and htt(Q47)-GFP were virtually undetectable. After autophagy 
shutoff, there was a robust increase in the level of htt(Q47)-GFP, as detected by GFP Western blot, whereas there was very little or no detectable increase 
in htt(Q25)-GFP, GAPDH, LDH, or chFP. (D) Quantitative flow cytometry time course analysis measuring selective autophagy in live cells. The ASI is the ratio 
of the relative increase in green and red fluorescence, as assessed by two-color flow cytometry, in response to dox. In control experiments, the ASI of two 
soluble, nonaggregating proteins, htt(Q25)-GFP and chFP, was 1. In contrast, the ASI of the aggregation-prone protein, htt(Q47)-GFP, compared with chFP 
after autophagy shutoff (+dox; 100 h) was 2. Data represent three independent experiments performed on different days. **, P ≤ 0.01; ***, P ≤ 0.005. 547 Role of ubiquitin and aggregation in autophagy • Riley et al.
were sorted by gating on both GFP and chFP fluorescence. To further en-
rich the population of cells expressing the construct of interest, the cells 
were expanded and resorted an additional two times for a total of three 
sorts. The final sorted population was then used to sort single cells into 
each well of a 96-well plate. 10–20 single clones of each cell line were 
analyzed for GFP, chFP, Atg5, and LC3-II levels and the responsiveness to 
dox to ensure our results were not caused by a clonal phenomenon. All   
m5-7–derived  cell  lines  were  maintained  according  to  the  original  de-
scribed conditions with the exception that cells were not starved before 
any experiment (Hosokawa et al., 2006). In brief, cells were maintained 
in DME with 4.5 g/liter glucose and l-Gln without Na pyruvate (Media-
tech) containing 10% FBS with or without 10 ng/ml dox (Sigma-Aldrich) 
at 37°C in 5% CO2. Plasmid transfection was performed using Fugene 6 
(Roche) according to the manufacturer’s protocol. For experiments with 
proteasome inhibitor (MG132), the final concentration was 1 µM.
Cell lysis and immunoblot analysis
Cells were lysed in 50 mM Tris, pH 8.0, 150 mM NaCl, 1% Triton X-100, 
0.5% Na deoxycholate, and 0.1% SDS containing 1× protease inhibi-
tors (Roche). Extracts were sonicated and centrifuged at 14,000 rpm in a 
microcentrifuge (Eppendorf 5417c; F45-30-11 rotor at 14,000 rpm) for 
10 min at 4°C, and supernatants were quantified using the bicinchoninic 
acid (BCA) protein assay (Thermo Fisher Scientific). Protein was electro-
phoresed through Tris-Gly gels and transferred to polyvinylidene fluoride 
(Bio-Rad Laboratories). Membranes were probed overnight at 4°C with 
antibody. Protein was visualized with ECL plus (GE Healthcare) and quanti-
fied using the Typhoon Imager (GE Healthcare) and ImageQuant software 
(Molecular Diagnostics).
Flow cytometry
We used the FlasherII Diva Digital equipped with a violet-enhanced kryp-
ton laser (407 nm), a dye laser (598 nm; em.625/40 nm), and a 488-nm 
laser (525/50 nm; Stanford University FACS facility). There was effectively 
no detectable bleed through between the GFP and chFP (and where appli-
cable violet 405) signals; however, the samples were compensated offline 
with FlowJo (Tree Star, Inc.) using cells expressing only single colors as 
controls. Cell death was measured using LIVE/DEAD Violet 405 (Invitrogen) 
according to the manufacturer’s protocol.
Poly-Ub affinity capture
Samples were prepared essentially as described previously (Bennett et al., 
2007). Brain hemispheres were homogenized for 90 s (pulsing) using  a 
Teflon micro-rotator in 600 µl of lysis buffer (1% Triton X-100, 150 mM 
NaCl, 20 mM Tris, pH 8.0, 10% glycerol, 10 mM N-ethylmaleimide 
[NEM], and complete protease inhibitor tablets, no EDTA [Roche]), fol-
lowed by sonication (3×) for 10–15 s. Lysates were then centrifuged 
(2×) for 10 min at 14,000 rpm in a microcentrifuge at 4°C followed by 1× 
for 5 min at 14,000 rpm in a microcentrifuge at 4°C. The insoluble frac-
tion was resuspended in 300 µl of 2% SDS followed by sonication (2×) 
for 15–30 s. Both the soluble and insoluble fractions were then spun for 
an additional 5 min at 14,000 rpm in a microcentrifuge (4°C for soluble 
and RT for insoluble) and then quantified using BCA (Thermo Fisher Scien-
tific). 1 mg of protein (soluble) was diluted to a final volume of 300 µl of 
the aforementioned lysis buffer (no NEM or protease inhibitors), to which   
75 µl human P2UBA resin (UBA domain from human ubiquilin 2 [UBQLN2] 
also known as PLIC-2; 1:1 slurry) was added and incubated overnight at 
4°C with constant rotation. 1 mg of protein (insoluble) was diluted into   
14 ml of lysis buffer (no NEM or protease inhibitors; final SDS concentration 
was 0.015%), to which 75 µl human P2UBA resin (1:1 slurry) was added 
and incubated overnight at 4°C with constant rotation.
Livers were homogenized in 0.25 M sucrose, 10 mM Hepes, pH 7.5,   
and  1  mM  DTT.  To  generate  Triton  X-100–soluble  and  –insoluble  frac-
tions, Triton X-100 (final concentration 1%) and NaCl (final concentration   
150 mM) were added, and the samples were vortexed and lysed on ice for 
15 min, followed by sonication (3×; 15 s). Lysates were then centrifuged 
they do not exclude the possibility that ubiquitination, either of 
substrates or components of the autophagy pathway, could play   
a permissive role in autophagy. The presence of a functional   
poly­Ub–binding UBA domain on the LC3­binding protein NBR1 
(Kirkin et al., 2009b), together with immunocytochemical evi­
dence of Ub within lysosomes (Schwartz et al., 1988; Doherty 
et al., 1989), suggests that proteins other than p62 may mediate 
an intimate relationship between the autophagy and Ub systems. 
Ub is a versatile signaling molecule that plays very different 
roles in a variety of cellular processes ranging from membrane 
trafficking to DNA repair (Chen and Sun, 2009; Finley, 2009). 
Further studies will be needed to more precisely elucidate its 
role in autophagy.
Materials and methods
Antibodies and reagents
Anti-LC3B polyclonal antibody was generated against the N-terminal 15 
residues from human LC3B (Iwata et al., 2005). Anti-Atg5 (SO4) and 
anti-Atg12 (NM2) polyclonal antibodies were provided by N. Mizushima 
(Mizushima et al., 2001). Anti-GFP monoclonal antibody was purchased 
from Roche. To detect chFP, we used Living Colors DsRed polyclonal anti-
body (Takara Bio Inc.). Anti-Ub monoclonal antibody (FK2) was obtained 
from Enzo Life Sciences, Inc. Anti-p62 polyclonal antibody was raised 
against the C terminus of p62 (residues 256–439) and was a gift from 
J. Shin (School of Medicine, Sungkyunkwan University, Suwon, South   
Korea). Rabbit Anti-LDH (H-160) was purchased from Santa Cruz Biotech-
nology, Inc., and monoclonal anti-GAPDH (clone 6C5) was purchased 
from  Millipore.  Dox  (Sigma-Aldrich)  was  prepared  in  water,  Geneticin 
(G418) was obtained from Invitrogen, and proteasome inhibitor (MG132) 
was obtained from Enzo Life Sciences, Inc. FuGENE 6 transfection reagent 
was purchased from Roche.
Plasmids
pcDNA3.1-chFP–-tubulin was a gift from R. Tsien (University of California, 
San Diego, La Jolla, CA; Shaner et al., 2004, 2005) and was used to cre-
ate pcDNA3.1-chFP. All of the bicistronic vectors used were generated 
from pIRES2-DsRed-Express (Takara Bio Inc.). The DsRed was removed, 
and constructs of interest were cloned in the multiple cloning site or the 
DsRed position (for the majority of constructs this was chFP). pcDNA3. 
1–htt(Q)-GFP constructs have been described previously (Kazantsev et al., 
1999; Bence et al., 2001), and the expression level of htt(Q)-GFP in the   
bicistronic reporter was comparable with commonly used pcDNA3.1–htt(Q)-
GFP constructs, as visualized by immunoblotting (Fig. S4 A), and by   
fluorescence microscopy, htt(Q47)-GFP formed characteristic inclusion 
bodies, whereas htt(Q25)-GFP and chFP were diffuse (Fig. S4 B). We also 
generated bicistronic constructs with htt(Q)-GFP expressed downstream of 
the IRES (Fig. S4 C); however, because expression of the gene downstream 
of the IRES is less robust than expression of the upstream gene (Fig. S4 C), 
htt(Q47)-GFP levels were below the threshold to form inclusion bodies visi-
ble by fluorescence microscopy (Fig. S4 D).
Cell culture and transfection
Atg5 Tet-Off cells were provided by from N. Mizushima and N. Hoso-
kawa (Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan), 
and generation of these cells has been previously described (Hosokawa 
et al., 2006). Clone m5-7 was further transfected with the aforementioned 
bicistronic constructs, pcDNA3.1-chFP or pcDNA3.1–htt(Q97)-GFP, and 
stable  transformants  were  selected  and  maintained  in  the  presence  of   
1 mg/ml G418 (Invitrogen). The cells expressing the bicistronic reporters 
(E) Flow cytometry time course analysis of cell death at different time points after autophagy shutoff (+dox). The degree of cell death correlated directly 
with increased htt(Q47)-GFP levels after autophagy shutoff and was significantly enhanced in cells expressing htt(Q47)-GFP compared with htt(Q25)-GFP   
(***, P ≤ 0.005). Data represent three independent experiments performed on different days. (F) AQUA using heavy isotope–labeled GFP standard in 
addition to the routine Ub standards after P2UBA pull-down of soluble and insoluble lysates from htt(Q)-GFP-IRES-chFP bicistronic expressing cells before 
(dox) and after autophagy shutoff (+dox). The experimental GFP peptide was only detected in two of the four experiments, and the data shown are 
representative of these. In the other two experiments, the experimental GFP peptide was below the threshold of detection. (D–F) Error bars indicate SEM. 
*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005.
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distribution and implemented in the R language. P-values were corrected 
for multiple testing using the Benjamini–Hochberg method (Benjamini and 
Hochberg, 1995). The set of Ub-associated genes was identified from 
annotation information from the UniProt database (UniProt Consortium, 
2008), Gene Ontology (Ashburner et al., 2000), and Panther classification 
(Thomas et al., 2003) systems.
Data analysis and linear modeling of gene expression  
microarray analysis
The microarray data analyzed have been deposited in NCBI Gene Expres-
sion Omnibus (GEO; Edgar et al., 2002) and are accessible through GEO 
series accession number GSE20415. Data analysis and linear modeling 
were performed in the R statistical programming language, using functions 
from linear models for microarray data (limma; Smyth, 2005). The moder-
ated t-statistic for each probe was computed using a Bayesian model. The 
associated p-value was adjusted to control the false discovery rate in multi-
ple testing using the Benjamini–Hochberg method (Benjamini and Hochberg, 
1995). Differentially expressed genes were identified with an adjusted   
p-value <0.05. Hierarchical clustering (centroid linkage method) was per-
formed with Cluster 3.0 (Eisen et al., 1998) using Pearson’s correlation   
as the similarity metric. Heat maps were generated using JavaTreeview 
(Saldanha, 2004).
Network analysis
A second-order network anchoring on core autophagy components was 
constructed from protein–protein interaction (PPI) data assembled from a 
large number of PPI data sources, including IntAct, BIND/BOND, GRID, 
MINT, HPRD, and DIP, and filtered for high confidence interactions using 
network topology and a set of reliability scoring metric as detailed in Lage 
et al. (2007). Enrichment of Ub-associated Nrf2 targets in the autophagy 
network was assessed using the hypergeometric distribution.
Statistical analysis
Single,  double,  and  triple  asterisks  denote  P  ≤  0.05,  P  ≤  0.01,  and   
P ≤ 0.005, respectively. The significance levels were determined using the 
unpaired t test.
Protein expression, purification, and p62-Ub binding assay
Pet28a-6xHis-p62(298–440) was a gift from J. Shin and was verified by 
sequencing. p62(298–440) was expressed in Escherichia coli BL21(DE3) 
(EMD) cells by the addition of 1 mM IPTG after the temperature was 
shifted from 37°C to 30°C at OD600 1.0. After 6 h of induction, cells 
were harvested, flash frozen in liquid nitrogen, and stored at 80°C 
for later use. For protein purification, frozen bacterial cells were resus-
pended in lysis buffer (50 mM Tris, pH 7.5, 500 mM NaCl, 0.5% Triton 
X-100, 10 mM imidazole, and 1 mM -mercaptoethanol) and lysed using 
a French press at 12,000 PSI (Thermo Fisher Scientific). Lysate was then 
centrifuged in a SS-34 rotor (Sorval) at 18,500 rpm for 60 min, and 
the  supernatant  was  incubated  in  batch  with  Ni-Sepharose  resin  (GE 
Healthcare) at 4°C for 4 h with gentle stirring. 6xHis-p62(298–440) was 
retained on the beads and washed three times with 4 bed vol of lysis 
buffer before elution with 50 mM Tris, pH 7.5, 500 mM NaCl, 0.5%   
Triton X-100, 250 mM imidazole, and 1 mM -mercaptoethanol. p62-
containing elutions were dialyzed into 50 mM of Tris buffer, pH 8, 50 mM 
NaCl, and 10 mM DTT and were loaded onto a hiTrap Q sepharose Fast 
Flow column (GE Healthcare) and eluted with a linear gradient of NaCl   
from 50 to 500 mM. p62 was further purified by gel filtration chromatog-
raphy  on  a  Sephacryl  S-200  column  (GE  Healthcare)  and  dialyzed   
into 20 mM Hepes, pH 7.0, and 100 mM NaCl before adding 1 mM Tris 
(2-carboxyethyl)phosphine and flash freezing aliquots in liquid nitrogen 
for storage at 80°C.
For p62-UBA binding assays, brain hemispheres were homogenized 
in 600 µl of lysis buffer (1% Triton X-100, 150 mM NaCl, 20 mM Tris,   
pH 8.0, 10% glycerol, 16 mM NEM, and complete protease inhibitor 
tablets, no EDTA [Roche]), followed by sonication (3×) for 10–15 s. Ly-
sates were then centrifuged (2×) for 10 min at 14,000 rpm in a micro-
centrifuge at 4°C then quantified using BCA. 1.2 mg of protein was diluted 
to a final volume of 450 µl of the aforementioned lysis buffer (no NEM or 
protease inhibitors), to which 50 µl of resin (1:1 slurry) was added and in-
cubated overnight at 4°C with constant rotation. Resins used were blocked   
Affigel-10  (Bio-Rad  Laboratories),  blocked  Sulfolink  (Thermo  Fisher 
Scientific), Affigel-P2UBA(575–624) (1 mg protein/ml resin), Affigel-
p62UBA(298–440) (1 mg protein/ml resin), and Sulfolink-p62UBA(298–
440). Samples were washed, eluted, and prepared for mass spectrometry 
as described in Poly-Ub affinity capture.
for 10 min at 14,000 rpm in a microcentrifuge at 4°C. The resulting super-
natant was used as the Triton X-100–soluble fraction, and the insoluble frac-
tion was resuspended in 2% SDS followed by sonication (3×; 15 s). Both 
the soluble and insoluble fractions were then spun for an additional 5 min 
at 14,000 rpm in a microcentrifuge (4°C for soluble and RT for insoluble) 
and then quantified using BCA. 2 mg of protein (soluble) was diluted to 
a final volume of 500 µl in 20 mM Tris, pH 7.6, 150 mM NaCl, and 1% 
Triton X-100, to which 60 µl human P2UBA resin (1:1 slurry) was added 
and incubated overnight at 4°C with constant rotation. 250 mg of protein 
(insoluble) was diluted into 14 ml of buffer (20 mM Tris, pH 7.6, 150 mM 
NaCl, and 1% Triton X-100), to which 60 µl human P2UBA resin (1:1 slurry) 
was added and incubated overnight at 4°C with constant rotation.
Mass spectrometry
Samples were prepared as described previously (Bennett et al., 2007). 
Mass spectrometry was also previously described (Bennett et al., 2007) 
with four additional ions that were measured by the AQUA method:   
human p62 (423–437; NYDIGAALDTIQYSK; unlabeled, m/z = 836.41; 
and heavy isotope labeled, m/z = 839.92), UbK6 (MQIFVK-[GG]-TLTGK; 
unlabeled, m/z = 460.60; and heavy isotope labeled, m/z = 462.93), 
linear Ub fusion (GGMQIFVK; unlabeled, m/z = 440.24; and heavy iso-
tope labeled, m/z = 443.23), and GFP (FEGDTLVNR; unlabeled, m/z = 
525.76; and heavy isotope labeled, m/z = 528.76). The GFP peptide is 
unique to GFP and is not found in chFP.
For Orbitrap analysis, the samples were analyzed by liquid chro-
matography tandem mass spectrometry using a previously described chro-
matography system and conditions (Bennett et al., 2007). The outlet of 
the chromatography column was directly coupled to a mass spectrometer 
(LTQ-Orbitrap XL; Thermo Fisher Scientific). Throughout the chromatogra-
phy run, three tandem mass spectrometry scans were performed in the 
linear ion-trap during each parent-ion Orbitrap scan. Orbitrap scans were 
acquired at a nominal resolution setting of 60,000. The relative intensities 
of the isotope-labeled standards and analytes were obtained by measur-
ing the intensities of the monoisotopic molecular ions after averaging 10 
scans across the elution profile of the standard.
Quantitative real-time RT-PCR analysis
Transcript levels of the Ub genes were measured as previously described (Ryu 
et al., 2008) with one change: the transcript levels were normalized to actin.   
For RT-PCR of the Ub-associated Nrf2 targets and Nqo1, the SuperScript 
First-Strand Synthesis system for RT-PCR (Invitrogen) was used, and cDNA 
was synthesized from 2 µg of total RNA. Quantitative PCR was performed with 
qPCR Mastermix or qPCR Mastermix Plus for SYBR Green I (Eurogentec S.A.) 
in an ABI 7700 system (Applied Biosystems). Ribosomal RNA was used 
as an internal control. The sequences of the primers used were as follows: 
Nqo1 forward, 5-AGCTGGAAGCTGCAGACCTG-3; Nqo1 reverse, 
5-CCTTTCAGAATGGCTGGCA-3; Nqo1 probe, 5-ATTTCAGTTCCCATT-
GCAGTGGTTTGGG-3; ribosomal RNA forward, 5-CGGCTACCACATC-
CAAGGAA-3; ribosomal RNA reverse, 5-GCTGGAATTACCGCGGCT-3; 
ribosomal RNA probe, 5-TGCTGGCACCAGACTTGCCCTC-3; Trim16 
forward, 5-AACAAAGAGGTGGACCTTCG-3; Trim16 reverse, 5-TTCA-
CCTCTGACACCGACAC-3; Usp20 forward, 5-TACCTGTGACCGGGT-
GTCTA-3; Usp20 reverse, 5-TGGTAGATGGCAGAGTGGAG-3; Fbxo25 
forward,  5-GTCGGGAACATCAACATCTG-3;  and  Fbxo25  reverse, 
5-TACCTGCTTTGTCACCTGGA-3.
Predicted transcription factor–binding site enrichment of  
Ub-associated genes
Transcription factor–binding sites were predicted by using the algorithm 
as described in Benita et al. (2009). In brief, we ran STORM (Smith et al., 
2006; Schones et al., 2007) to match position weight matrices (PWMs) 
in the JASPAR and TRANSFAC collections to genomic DNA. Conservation 
information was also incorporated into the prediction using multiSTORM 
(Smith et al., 2006) to achieve PWM matches across at least four organ-
isms. In addition, site-cons algorithm (Smith et al., 2006) was applied to 
compute the level of conservation at each binding site compared with the 
flanking 100 bases. Conservation information was obtained from genome 
alignments available from the University of California, Santa Cruz genome 
browser project (Karolchik et al., 2008). The predicted Nrf2 sites have a 
central core motif GGAAG, flanked by sequences that are more highly 
variable as specified by the PWM. Thus, there is no exact ARE sequence 
but rather a weighted consensus motif (TRANSFAC accession M00108 
and  ID  V$NRF2_01).  Enrichment  for  the  occurrence  of  transcription   
factor–binding sites in the promoter regions of Ub-associated genes against 
its representation genome wide was assessed using the hypergeometric 549 Role of ubiquitin and aggregation in autophagy • Riley et al.
Invitrogen) and 50 µg/ml bisbenzimide and finally mounted using glycerol/
gelatin N-propyl gallate. Conventional epifluorescence micrographs were 
obtained on a microscope (Axiovert 200M; Carl Zeiss, Inc.) with a 100× 
NA 1.4 oil lens (Carl Zeiss, Inc.) or 40× NA 0.75 air objection (Carl Zeiss, 
Inc.). Digital (12 bit) images were acquired with a cooled charge-coupled 
device  (Roper  Industries)  and  processed  by  using  MetaMorph  software 
(Universal Imaging). For bisbenzimide (Ex. 365/50, Em. 450/65), GFP 
(Ex.490/20, Em. 535/20) and chFP (Texas red; Ex.560/55, Em. 645/75) 
the dichroics were: 400/LP (bisbenzimide), 500/LP (GFP or Alexa Fluor 
488), and 595/LP (chFP or Alexa Fluor 594). Scale bars equal 1 µm.
Genotype of animals
The genotypes of the animals used in this study are shown in Table I.
Online supplemental material
Fig. S1 shows the comparison of p62-UBA and P2UBA Ub binding. Fig. S2 
shows quantitative real-time PCR validation of the Nrf2 Ub-associated 
genes identified by microarray. Fig. S3 shows that selective accumulation 
of htt(Q47)-GFP over chFP after autophagy shutoff is not caused by differ-
ences in cap-dependent versus cap-independent translation or proteasome 
inhibition. Fig. S4 shows Western blot and fluorescence microscopy analy-
sis of the bicistronic constructs. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201005012/DC1.
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[
35S]Met incorporation
For radioactive labeling of newly synthesized proteins, cells were washed 
twice  before  starvation  in  Cys-/Met-free  media  (15  min),  followed  by 
labeling with [
35S]Met (250 µCi/10-cm dish) for 1, 2, and 3 h. At the 
different time points, the plates were washed with 3× ice-cold PBS, and 
cells were scraped off plates and harvested at 1,000 g for 5 min. Lysis 
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.5% Na 
deoxycholate, and 0.1% SDS containing 1× protease inhibitors [Roche]) 
was added, and the cells were vortexed and incubated on ice for 15 min 
followed by syringe lysis (10x, 21cc, 4x, and 25cc) followed by centrifu-
gation at 4°C (10 min at 14,000 rpm in a microcentrifuge). The resulting 
supernatants were spotted on Whatman paper and boiled in 10% TCA to 
remove tRNAs. The [
35S]Met incorporation was then measured by scintilla-
tion counting, and equal amounts of [
35S]Met were used for the 1-, 2-, and 
3-h immunoprecipitations.
Northern blotting
Total RNA was prepared using RNeasy Plus (QIAGEN) followed by mRNA 
purification (2×) from 125 µg of total RNA using Oligo25 beads (Invitro-
gen). Northern blot analysis was performed as described previously (Streit   
et al., 2009) with the exception that probes were digoxigenin (DIG)   
labeled (Roche). To determine the size of the transcript, we used a single-
stranded RNA ladder (New England Biolabs, Inc.). The actin DIG-labeled 
RNA probe (588 bases) was purchased from Roche and used to detect 
actin (1.8 kb). A chFP probe (584 bases) was constructed by PCR using 
pcDNA3.1-chFP as a template and 5-GTGAGCAAGGGCGAGGAG-3  
as  the  forward  primer  and  5-TAATACGACTCACTATAGGGCTTGTA-
CAGCTCGTCCATG-3 as the reverse primer (t7 tag is underlined). The 
resulting PCR product was used in the in vitro transcription reaction with 
DIG-11-UTP (Roche) to make the DIG-labeled chFP probe used to detect 
htt(Q47)-GFP-IRES-chFP (2.4 kb).
Microscopy
For direct fluorescence, cells were grown on glass coverslips, fixed in 4% 
paraformaldehyde, permeabilized by 0.2% Triton X-100, and stained for 
20 min in 50 µg/ml bisbenzimide (Sigma-Aldrich) for nuclear staining and 
mounted using glycerol/gelatin N-propyl gallate. For immunofluorescence, 
cells were fixed, permeabilized, and blocked with 5% BSA in PBS followed 
by primary antibody incubation at 37°C for 1 h, washing in PBS, incuba-
tion for 1 h at 37°C with secondary antibodies (Alexa Fluor 488 or 594; 
Table I.  Genotype of animals
Name Genotype n Tissue Age
wk
control (Atg5) F/+:Nes 4 brain 16
control (Atg5) F/+:Nes 3 brain 26
Atg5 KO F/F:Nes 4 brain 16
Atg5 KO F/F:Nes 3 brain 26
control (Atg7) F/+:Nes:p62
+/ 2 brain 6
control (Atg7) F/F:p62
+/ 1 brain 6
control (Atg7) F/F:p62
+/:GFP-LC3
+/ 1 brain 6
Atg7 KO F/F:Nes 1 brain 6
Atg7 KO F/F:Nes:p62
+/:GFP-LC3
+/ 2 brain 6
p62 KO F/+:p62
/ 1 brain 6
p62 KO F/F:p62
/ 1 brain 6
p62 KO F/F:p62
/:GFP-LC3
+/ 1 brain 6
Atg7-/p62-DKO F/F:Nes:p62
/ 2 brain 6
Atg7-/p62-DKO F/F:Nes:p62
/:GFP-LC3
+/ 1 brain 6
control (Atg7) F/F 2 liver 6
control (Atg7) F/F:Nrf2
+/ 2 liver 6
Atg7 KO F/F:Mx1 2 liver 6
Atg7 KO F/F:Mx1:Nrf2
+/ 3 liver 6
Atg7 KO F/F:Mx1:Nrf2
+/:GFP-LC3
+/ 1 liver 6
Nrf2 KO F/F:Nrf2
/ 3 liver 6
Nrf2 KO F/F:Nrf2
/:GFP-LC3 1 liver 6
Atg7-/Nrf2-DKO F/F:Mx1:Nrf2
/ 5 liver 6
Atg7-/Nrf2-DKO F/F:Mx1:Nrf2
/:GFP-LC3
+/ 1 liver 6JCB • VOLUME 191 • NUMBER 3 • 2010   550
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